FDA Inspection 1133484 — Haupt Pharma Wolfratshausen GmbH
The FDA completed an inspection of Haupt Pharma Wolfratshausen GmbH on Aug 5, 2020 in Wolfratshausen. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Aug 5, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Wolfratshausen (Germany)
Additional details
Mutual Recognition Agreement (MRA)